Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases.

MLA

Singh, Siddharth, et al. “Systematic Review with Meta-Analysis: Association between Vedolizumab Trough Concentration and Clinical Outcomes in Patients with Inflammatory Bowel Diseases.” Alimentary Pharmacology & Therapeutics, vol. 50, no. 8, Oct. 2019, pp. 848–57. EBSCOhost, https://doi.org/10.1111/apt.15484.

APA

Singh, S., Dulai, P. S., Vande Casteele, N., Battat, R., Fumery, M., Boland, B. S., & Sandborn, W. J. (2019). Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics, 50(8), 848–857. https://doi.org/10.1111/apt.15484

Chicago

Singh, Siddharth, Parambir S Dulai, Niels Vande Casteele, Robert Battat, Mathurin Fumery, Brigid S Boland, and William J Sandborn. 2019. “Systematic Review with Meta-Analysis: Association between Vedolizumab Trough Concentration and Clinical Outcomes in Patients with Inflammatory Bowel Diseases.” Alimentary Pharmacology & Therapeutics 50 (8): 848–57. doi:10.1111/apt.15484.